Gram-negative bacilli-derived peptide antibiotics developed since 2000

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Gram-negative bacilli synthesize numerous short peptides (<30 residues).
• These peptides show promise as pharmaceutical drugs and biocontrol agents.
• Increasing antibiotic resistance necessitates novel therapeutic compounds.

Purpose of the Study:

• To review Gram-negative bacilli-derived peptides reported since 2000.
• To summarize the structures and activities of these peptides.
• To discuss their therapeutic and biocontrol potential.

Main Methods:

• Literature review of scientific publications from 2000 onwards.
• Categorization of peptides based on structural class (e.g., lipopeptides, thiopeptides).
• Compilation of reported biological activities.

Main Results:

• 150 Gram-negative bacilli-derived compounds were identified.
• Peptides include cyclic lipopeptides (40 from Pseudomonas spp.), aromatic peptides, glycopeptides, linear lipopeptides, thiopeptides, lasso peptides, cyclic peptides, and linear peptides.
• Activities encompass antituberculotic, anti-cyanobacterial, antifungal, antibacterial, antiviral, insecticidal, and antiprotozoal effects.

Conclusions:

• Gram-negative bacilli are a rich source of novel bioactive peptides.
• These peptides exhibit a broad spectrum of activities, indicating significant therapeutic and biocontrol potential.
• Further research into these compounds could lead to new drug and agent development.